SCHEMBL6138149

SCHEMBL6138149

CC(C)Oc1ccc(N=C(N)N)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 2/20 0.62
HTR3B O95264 2/20 0.62
HTR3A P46098 2/20 0.62
HTR3D Q70Z44 2/20 0.62
HTR3C Q8WXA8 2/20 0.62
ADRA2A P08913 6/20 0.61
ADRA2B P18089 4/20 0.61
ADRA2C P18825 4/20 0.61
POLB P06746 1/20 0.56
FURIN P09958 2/20 0.53
PARP10 Q53GL7 1/20 0.53
SCN5A Q14524 1/20 0.52
SCN2A Q99250 1/20 0.52
PLAU P00749 2/20 0.52
SLC22A2 O15244 1/20 0.52
SLC22A1 O15245 1/20 0.52
SLC22A3 O75751 1/20 0.52
PRSS1 P07477 2/20 0.50
ACR P10323 1/20 0.50
GLA P06280 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17590500 0.79 SCN2A (0.71) POLBPARP10SCN5ASCN2APLAU
SCHEMBL4099711 0.77 HTR3E (1.00) HTR3EHTR3BHTR3AHTR3DHTR3C
Hydrochloric Acid SCHEMBL5635577 0.75 HTR3E (0.96) HTR3EHTR3BHTR3AHTR3DHTR3C
Hydrogen Peroxide SCHEMBL28902806 0.75 KMT2A (0.70) POLBPARP10GLA
SCHEMBL125543 0.75 ALDH1A3 (0.64) POLBPARP10GLA
SCHEMBL18836850 0.73 PARP10 (0.46) POLBPARP10SCN5ASCN2AGLA
SCHEMBL17590302 0.73 HTR3E (0.54) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL19569860 0.72 ALDH1A3 (0.52) POLBPARP10SCN5ASCN2AGLA
SCHEMBL4099965 0.72 ADRA2A (1.00) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5501717 0.71 P2RY6 (0.48) POLBPARP10SCN5ASCN2AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed
EP-2604595-B1 TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOUND THAT CONTAINS SAME AND EXHIBITS ANALGESIC ACTIVITY SHIONOGI & CO (JP) 2016-03-16 EP disclosed